FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace FDA's Formal Position on Enforcement Discretion Revealed Vapor Technology Association The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York